URL: http://www.mapinc.org/drugnews/v18/n103/a02.html
Newshawk: http://drugpolicycentral.com/bot/
Pubdate: Thu, 19 Apr 2018
Source: Times-Picayune, The (New Orleans, LA)
Copyright: 2018 The Times-Picayune
Contact:
Website: http://www.nola.com/t-p/
Details: http://www.mapinc.org/media/848
US EXPERTS BACK MARIJUANA-BASED DRUG FOR CHILDHOOD SEIZURES
WASHINGTON -- A medicine made from the marijuana plant moved one step
closer to U.S. approval Thursday after federal health advisers
endorsed it for the treatment of severe seizures in children with epilepsy.
If the Food and Drug Administration follows the group's
recommendation, GW Pharmaceuticals' syrup would become the first drug
derived from the cannabis plant to win federal approval in the U.S.
The 13-member FDA panel voted unanimously in favor of the experimental
medication made from a chemical found in cannabis -- one that does not
get users high. The panelists backed the drug based on three studies
showing that it significantly reduced seizures in children with two
rare forms of childhood epilepsy.
[Remainder snipped]
MAP posted-by: Matt
|